Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival. (Q52941765)
Jump to navigation
Jump to search
scientific article published in February 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival. |
scientific article published in February 2005 |
Statements
Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival. (English)
1 reference
1 reference
Manfred Dietel
1 reference
Glen Kristiansen
1 reference
Christoph Wissmann
1 reference
Simone Kaiser
1 reference
Thomas Bruemmendorf
1 reference
Stefan Roepcke
1 reference
Edgar Dahl
1 reference
Bernd Hinzmann
1 reference
Thomas Specht
1 reference
Janja Pervan
1 reference
Carsten Stephan
1 reference
Stefan Loening
1 reference
André Rosenthal
1 reference
1 February 2005
1 reference
205
1 reference
3
1 reference
359-376
1 reference
1 reference
1 reference
1 reference